CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy

被引：3
|
作者：
Ko, Ji Su [1 ,2 ]
Lee, Jeong Hyun [1 ,2 ,4 ,5 ]
Yoon, Dok Hyun [3 ]
Suh, Chong Hyun [1 ,2 ]
Chung, Sae Rom [1 ,2 ]
Choi, Young Jun [1 ,2 ]
Baek, Jung Hwan [1 ,2 ]
机构：
[1] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea
[2] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea
[3] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
[4] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[5] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
来源：
KOREAN JOURNAL OF RADIOLOGY | 2024年 / 25卷 / 04期
关键词：
Acute lymphoblastic leukemia; Adoptive immunotherapy; Chimeric antigen receptor (CAR) T cells; CAR-T cell associated side effects; Cytokine-release syndrome; MANAGEMENT;
D O I：
10.3348/kjr.2023.1100
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：399 / 402
页数：4
相关论文
共 50 条
  • [1] Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy
    Acharya, Utkarsh H.
    Dhawale, Tejaswini
    Yun, Seongseok
    Jacobson, Caron A.
    Chavez, Julio C.
    Ramos, Jorge D.
    Appelbaum, Jacob
    Maloney, David G.
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (03) : 195 - 205
  • [2] Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy
    Zhang, Lina
    Wang, Shuai
    Xu, Ji
    Zhang, Run
    Zhu, Han
    Wu, Yujie
    Zhu, Liying
    Li, Jianyong
    Chen, Lijuan
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [3] Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy
    Lina Zhang
    Shuai Wang
    Ji Xu
    Run Zhang
    Han Zhu
    Yujie Wu
    Liying Zhu
    Jianyong Li
    Lijuan Chen
    Experimental Hematology & Oncology, 10
  • [4] Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
    Kotch, Chelsea
    Barrett, David
    Teachey, David T.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (08) : 813 - 822
  • [5] Cytokine Release Syndrome after Chimeric Antigen Receptor Transduced T-Cell Therapy in Cancers: A Systematic Review
    Taheri, Saeed
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2022, 33 (06) : 795 - 823
  • [6] Recent advances in the prevention and management of cytokine release syndrome after chimeric antigen receptor T-cell therapy
    Shi, Xiaoxue
    Wu, Hongfang
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [7] Cytokine signaling in chimeric antigen receptor T-cell therapy
    Kagoya, Yuki
    INTERNATIONAL IMMUNOLOGY, 2024, 36 (02) : 49 - 56
  • [8] Adjuvant ruxolitinib therapy relieves steroid-refractory cytokine-release syndrome without impairing chimeric antigen receptor-modified T-cell function
    Wei, Shuning
    Gu, Runxia
    Xu, Yingxi
    Liu, Xiaoyu
    Xing, Yanyan
    Gong, Xiaoyuan
    Zhou, Chunlin
    Liu, Bingcheng
    Zhang, Guangji
    Liu, Kaiqi
    Wei, Hui
    Mi, Yingchang
    Wang, Min
    Wang, Ying
    Wang, Jianxiang
    IMMUNOTHERAPY, 2020, 12 (14) : 1047 - 1052
  • [9] Prognostic Significance of Cytokine Release Syndrome in B Cell Hematological Malignancies Patients After Chimeric Antigen Receptor T Cell Therapy
    Dong, Rujiao
    Jiang, Songfu
    Chen, Yi
    Ma, Yongyong
    Sun, Lan
    Xing, Chongyun
    Zhang, Shenghui
    Yu, Kang
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2021, 41 (12) : 469 - 476
  • [10] Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights
    Obstfeld, Amrom E.
    Frey, Noelle V.
    Mansfield, Keith
    Lacey, Simon F.
    June, Carl H.
    Porter, David L.
    Melenhorst, Jan J.
    Wasik, Mariusz A.
    BLOOD, 2017, 130 (23) : 2569 - 2572
12345